Celestial Biolabs Stock Price, News & Analysis
EAC
NASDAQ
Company Description
Celestial Biolabs (NASDAQ: EAC) is a publicly traded company.
EAC stock has declined 100.0% over the past year.
This page provides a comprehensive overview of EAC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-100%
Performance 1 year
$0.0
22.6M
Celestial Biolabs (EAC) stock. Over the past 12 months, the stock has lost 100.0%.
Latest News
Celestial Biolabs has 7 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, earnings, IPO, offering. View all EAC news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months